Future Pharmacology is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Future Pharmacology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Future Pharmacology has published 254 articles. Articles are minted with DOIs through the prefix 10.3390.
Keywords
drug design and discovery, clinical pharmacology, cellular pharmacology, neuropharmacology, drug misuse and addiction, biopharmaceuticals
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2021
- DOI prefix
10.3390
ISSN
- electronic
- 2673-9879
Frequently asked questions
Is Future Pharmacology peer-reviewed?
Yes — Future Pharmacology operates a Anonymous peer review review process.
Does Future Pharmacology charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Future Pharmacology publish?
Future Pharmacology publishes research in Therapeutics. Pharmacology.
What languages does Future Pharmacology accept?
Future Pharmacology accepts manuscripts in English.
What is the ISSN of Future Pharmacology?
ISSN:
2673-9879 (electronic).How do I submit a manuscript to Future Pharmacology?
Submit through the journal's official portal: visit submission page →